Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang...
JZT: Net profit in the third quarter was 7.758 million yuan, a decrease of 78.30%
JZT released its performance for the first half of the year, with a net profit attributable to the parent company of 144 million yuan, a year-on-year decrease of 29.71%
The concept of innovative drugs fluctuates and rebounds, JZT hits the limit up
JZT's stock hit the upper limit and achieved a 2-day consecutive increase, with a cumulative rise of 21.0%
Innovative drug concept stocks rebound after hitting bottom, JZT reaches the daily limit
The concept of innovative drugs fluctuates and rebounds, ClinPlus rises over 10%